01Start here
Product introduction
ROSUWIP-F contains a statin and a fibric-acid derivative in one tablet. The combination is used within a broader lipid-management plan that may also include nutrition, physical activity, weight management and follow-up blood tests.
It is not a medicine for immediate symptom relief. Treatment goals, duration and monitoring should be individualised by the prescriber using the approved local product literature.
Important contextThis page explains the composition and general ingredient context. The approved local product label remains the authority for indication, dose, contraindications and monitoring.
02Clinical context
Uses of ROSUWIP-F
- ✓Clinician-directed management of mixed dyslipidaemia when control of both cholesterol and triglyceride-related parameters is required.
- ✓Adjunct to diet and other lifestyle measures—not a replacement for them.
- ✓Use only when the prescriber considers the benefits of the combination greater than its muscle, liver, gallbladder and kidney-related risks.
Benefits and product context
01Dual lipid targets
Rosuvastatin primarily lowers LDL cholesterol, while fenofibrate has a stronger effect on triglyceride-rich particles.
02Single-tablet format
Combines two prescribed components in one dosage form when a clinician has selected both for the same patient.
03Monitored care
Supports a structured plan in which response and safety can be followed with clinical review and laboratory testing.
03Know what to watch for
Side effects and warning signs
Possible effects include headache, nausea, abdominal discomfort, constipation and muscle aches. Not everyone experiences side effects.
!Unexplained muscle pain, tenderness or weakness
!Dark urine, marked fatigue or fever
!Yellowing of the skin or eyes
!Severe upper-abdominal pain or allergic symptoms
When to seek helpSeek prompt medical advice for significant muscle symptoms, dark urine, jaundice, severe abdominal pain or swelling/breathing difficulty.
↗
AdministrationHow to use ROSUWIP-F
Take only in the dose and schedule printed on the prescription or approved product label. Take it consistently, continue the diet and activity plan advised to you, attend requested blood tests, and never double a missed dose unless your clinician specifically instructs you to do so.
◎
MechanismHow it works
Rosuvastatin inhibits HMG-CoA reductase, reducing hepatic cholesterol synthesis and increasing clearance of LDL particles. Fenofibrate activates PPAR-alpha pathways that influence triglyceride-rich lipoprotein metabolism. Using them together can address different parts of the lipid profile, but can also increase the need for muscle, liver and kidney safety monitoring.
04Use with care
Safety advice
01
Pregnancy
Specialist decisionLipid-lowering treatment is usually reassessed during pregnancy. Contact the prescriber promptly if pregnant or planning pregnancy.
02
Breastfeeding
Consult your doctorA clinician should assess whether this product is appropriate while breastfeeding.
03
Driving
Use cautionDo not drive or operate machinery if you feel dizzy, drowsy or unwell after taking the medicine.
04
Kidney health
Dose/monitoring reviewFenofibrate exposure and muscle risk can increase with impaired kidney function. Renal assessment may be needed before and during therapy.
05
Liver health
Monitoring requiredActive liver disease and unexplained liver-test abnormalities require medical assessment; periodic tests may be advised.
Practical checklistQuick tips
Small steps that support safer, more informed use.
- ✓Keep follow-up lipid, liver and kidney tests.
- ✓Report unexplained muscle symptoms without delay.
- ✓Avoid starting another lipid medicine or supplement without checking first.
- ✓Continue the diet and activity plan advised by your clinician.
- ✓Tell every prescriber that you take both rosuvastatin and fenofibrate.
05At a glance
Product fact box
Product categoryPrescription medicine
Therapy areaCardio Care
Dosage formTablet
Habit formingNo known habit-forming potential
CompanyWipzo Healthcare Private Limited
Information statusProfessional reference
06Medicine review
Interactions and combinations
Give your prescriber or pharmacist a complete list of prescription medicines, over-the-counter products, vitamins, herbals and supplements.
ReviewOther lipid medicines
Gemfibrozil, other fibrates and some cholesterol medicines can increase muscle-related risk.
ReviewAnticoagulants
Fenofibrate can affect coumarin anticoagulants; clotting tests and dose review may be required.
ReviewSelected antivirals and immunosuppressants
Some agents can alter statin exposure or kidney function. Provide a complete medicines list to the prescriber.
07Common questions
Frequently asked questions
Is ROSUWIP-F a cholesterol medicine?+
It combines two lipid-modifying medicines. Whether it is appropriate depends on the individual lipid pattern, medical history and current treatment.
Can I stop it when my reports improve?+
Do not stop or alter treatment on your own. Improved results may reflect the combined effect of medicine and lifestyle measures.
Why are blood tests important?+
Tests help the clinician assess lipid response and monitor liver, kidney or muscle-related concerns when clinically indicated.
Can I take it with other cholesterol medicines?+
Only after the prescriber or pharmacist checks the full combination for interactions and overlapping muscle risk.
Ingredient-information references
General ingredient context was reviewed against authoritative health or regulatory resources. These links are not a substitute for the approved Wipzo product label.
